L Brands Commences Exchange Offers for Certain Outstanding

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
67
L Brands Commences Exchange Offers for Certain Outstanding Senior Notes Due 2020, 2021 and 2022

COLUMBUS, Ohio, May 31, 2018 (GLOBE NEWSWIRE) -- L Brands, Inc. (the “Company”) (NYSE: LB ) announced today the commencement of offers to eligible holders of the Company’s outstanding senior notes listed in the table below (collectively, the “Outstanding Notes”) to exchange Outstanding Notes for up to (x) $700,000,000 aggregate principal amount (the “New Issue Cap”) of the Company’s new notes due January 2027  (the “New Notes”) and (y) cash (the “Offers”).

The purpose of the Offers is to extend the maturity of the debt obligations associated with the Outstanding Notes.

The Offers are being conducted by the Company upon the terms and subject to the conditions set forth in a confidential offering memorandum, dated May 31, 2018 (the “Confidential Offering Memorandum”).

The following table sets forth the Outstanding Notes that are subject to the Offers:

                            Composition of Total Exchange Consideration(1)(2)  
CUSIP   Title of Security     Principal Amount Outstanding   Acceptance Priority Level     Series Tender Cap   Reference U.S. Treasury Security   Bloomberg Reference Page   Fixed Spread (Basis Points)   Early Participation Premium (New Notes)   New Notes Component     Hypothetical Cash Component (3)   Hypothetical Total Exchange Consideration (4)
532716AS6   7.000% Senior Notes due 2020   $400,000,000   1     N/A   1.375% due April 30, 2020   PX5   50   $50.00   $850.00   $174.30   $1,074.30
532716AT4   6.625% Senior Notes due 2021   $1,000,000,000   2     N/A   2.250% due March 31, 2021   PX5   80   $50.00   $850.00   $187.78   $1,087.78
532716AU1   5.625% Senior Notes due 2022   $1,000,000,000   3   $100,000,000   2.000% due February 15, 2022   PX5   190   $50.00   $950.00   $37.73   $1,037.73
(1) For each $1,000 principal amount of Outstanding Notes validly tendered, not validly withdrawn and accepted by us for exchange.
(2) The Total Exchange Consideration will be paid in a combination of (a) a principal amount of New Notes (the “New Notes Component”), (b) an amount of cash equal to the cash component (the “Cash Component”) and (c) a principal amount of New Notes equal to the Early Participation Premium (exclusive of accrued interest).
(3) The value of the hypothetical Cash Component equals the hypothetical Total Exchange Consideration minus the New Notes Component minus the Early Participation Premium. The hypothetical Cash Components shown in the table above are shown for illustrative purposes only. The actual Cash Components will be known on the price determination date when the actual Exchange Consideration and Total Exchange Consideration are determined.
(4) The hypothetical Total Exchange Consideration for each note is shown for illustrative purposes only. The Total Exchange Consideration will be calculated in accordance with the formula included in the Confidential Offering Memorandum.
   

Upon the terms and subject to the conditions of the Offers set forth in the Confidential Offering Memorandum, the Company is making three separate exchange offers to eligible holders to exchange the Company’s outstanding (1) 7.000% Senior Notes due 2020, (2) 6.625% Senior Notes due 2021 and (3) 5.625% Senior Notes due 2022 for up to (x) $700,000,000 aggregate principal amount of New Notes and (y) cash, provided that no more than $100,000,000 aggregate principal amount of New Notes will be issued in exchange for outstanding 5.625% Senior Notes due 2022.The Outstanding Notes will be accepted for exchange based on the “acceptance priority level” (in numerical priority order) as set forth in the table above and proration as described in the Confidential Offering Memorandum. In addition, all Outstanding Notes that are tendered for exchange in an Offer on or before the early participation date will have priority over Outstanding Notes that are tendered for exchange after the early participation date, regardless of their acceptance priority level. Accordingly, if accepting all Outstanding Notes validly tendered on or before the early participation date would result in us issuing New Notes in excess of the New Issue Cap, the Company will not accept any Outstanding Notes tendered after the early participation date.

L Brands reserves the right to upsize the new issue cap or the 2022 cap at its discretion.

The total exchange consideration for the Outstanding Notes will be based on a fixed-spread pricing formula using the bid-side yield applicable on the applicable Reference U.S. Treasury Security set forth in the table above and the applicable fixed spread set forth in the table above, and will be calculated at 11:00 a.m., New York City time, on June 14, 2018, unless the early participation date (as described below) is extended by more than two full business days, in which case a new date and time may be established with respect to the Offers, and will be paid in a combination of New Notes and cash in an aggregate principal amount determined as set forth in the Confidential Offering Memorandum. The Total Exchange Consideration includes an Early Participation Premium in an amount set forth in the table above payable in principal notes only to eligible holders who validly tender and who do not validly withdraw their Outstanding Notes on or prior to the early participation date of 5:00 p.m., New York City time, on June 13, 2018, subject to any extension by the Company.

The New Notes will mature on January 15, 2027 and will bear interest at a rate per annum equal to the sum of (i) the bid-side yield on the 10-Year Treasury on the price determination date (based on the bid-side price indicated on the Bloomberg reference page PX1 at such date and time) and (ii) 3.750% (375 basis points).

The Offers will expire at 11:59 p.m., New York City time, on June 27, 2018, unless extended by the Company. Tenders of Outstanding Notes in the Offers may be validly withdrawn at any time at or prior to 5:00 p.m., New York City time, on June 13, 2018, subject to extension by the Company, but not thereafter, except in certain limited circumstances where additional withdrawal rights are required by law.

The Offers are subject to certain conditions, including (i) the condition that, with respect to all the offers on an aggregate basis, we receive valid tenders on or prior to the early participation date that are not validly withdrawn of enough Outstanding Notes so that at least $300,000,000 aggregate principal amount of New Notes will be issued in exchange for Outstanding Notes, (ii) the condition that, on the price determination date, the combination of the yield of the New Notes and the Total Exchange Consideration or Exchange Consideration for the applicable series of Outstanding Notes would result in the New Notes and such Outstanding Notes not being treated as “substantially different” under ASC 470-50 and (iii) with respect to any Outstanding Notes validly tendered and not validly withdrawn pursuant to any offer that will be exchanged on the final settlement date, the condition that we determine that the New Notes to be issued on the final settlement date in such offer will be treated as part of the same issue as the New Notes, if any, issued on the early settlement date for U.S. federal income tax purposes pursuant to specified tests.

The New Notes have not been registered under the Securities Act of 1933 (as amended, the “Securities Act”) or any state securities laws. Therefore, the New Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and any applicable state or foreign securities laws. The New Notes may not be offered or sold in the United States or to any U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the offers are being made, and the New Notes are being offered and will be issued, only to (1) “qualified institutional buyers” as defined in Rule 144A under the Securities Act (“QIBs”), and (2) outside the United States, to persons other than “U.S. persons” as defined in Rule 902 under the Securities Act in compliance with Regulation S under the Securities Act (such holders, the “eligible holders”). Only eligible holders who have completed and returned an eligibility certification (the “eligibility certification”), available from D.F. King & Co., are authorized to receive and review the offering memorandum and to participate in the offers. The Company will enter into a registration rights agreement with respect to the New Notes.

Documents relating to the Offers will only be distributed to holders of the Outstanding Notes that complete and return a letter of eligibility confirming that they are eligible holders. Holders of the Outstanding Notes that desire a copy of the eligibility letter may contact D.F. King & Co., Inc., the information agent for the Offers, by calling toll-free at (212) 269-5550 or toll free at (888) 548-6498 or e-mailing lb@dfking.com. Holders of the Outstanding Notes may also complete and submit a letter of eligibility online at www.dfking.com/lb.

This press release is not an offer to sell or a solicitation of an offer to buy any security. The Offers are being made solely pursuant to the Confidential Offering Memorandum and only to such persons and in such jurisdictions as is permitted under applicable law.

ABOUT L BRANDS:

L Brands, through Victoria’s Secret, PINK, Bath & Body Works, La Senza and Henri Bendel, is an international company.  The company operates approximately 3,070 company-owned specialty stores in the United States, Canada, the United Kingdom, Ireland and Greater China, and its brands are sold in more than 800 additional franchised locations worldwide.  The company’s products are also available online at www.VictoriasSecret.com , www.BathandBodyWorks.com , www.HenriBendel.com and www.LaSenza.com .

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this press release or made by our company or our management involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Words such as “estimate,” “project,” “plan,” “believe,” “expect,” “anticipate,” “intend,” “planned,” “potential” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, in some cases have affected and in the future could affect our financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements included in this press release or otherwise made by our company or our management:

  • general economic conditions, consumer confidence, consumer spending patterns and market disruptions including severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events;
  • the seasonality of our business;
  • the dependence on mall traffic and the availability of suitable store locations on appropriate terms;
  • our ability to grow through new store openings and existing store remodels and expansions;
  • our ability to successfully expand internationally and related risks;
  • our independent franchise, license and wholesale partners;
  • our direct channel businesses;
  • our ability to protect our reputation and our brand images;
  • our ability to attract customers with marketing, advertising and promotional programs;
  • our ability to protect our trade names, trademarks and patents;
  • the highly competitive nature of the retail industry and the segments in which we operate;
  • consumer acceptance of our products and our ability to manage the life cycle of our brands, keep up with fashion trends, develop new merchandise and launch new product lines successfully;
  • our ability to source, distribute and sell goods and materials on a global basis, including risks related to: •   political instability, significant health hazards, environmental hazards or natural disasters; •   duties, taxes and other charges; •   legal and regulatory matters; •   volatility in currency exchange rates; •   local business practices and political issues; •   potential delays or disruptions in shipping and transportation and related pricing impacts; •   disruption due to labor disputes; and •   changing expectations regarding product safety due to new legislation;
  • our geographic concentration of vendor and distribution facilities in central Ohio;
  • fluctuations in foreign currency exchange rates;
  • stock price volatility;
  • our ability to pay dividends and related effects;
  • our ability to maintain our credit rating;
  • our ability to service or refinance our debt;
  • our ability to retain key personnel;
  • our ability to attract, develop and retain qualified associates and manage labor-related costs;
  • the ability of our vendors to deliver products in a timely manner, meet quality standards and comply with applicable laws and regulations;
  • fluctuations in product input costs;
  • our ability to adequately protect our assets from loss and theft;
  • fluctuations in energy costs;
  • increases in the costs of mailing, paper and printing;
  • claims arising from our self-insurance;
  • our ability to implement and maintain information technology systems and to protect associated data;
  • our ability to maintain the security of customer, associate, third-party or company information;
  • our ability to comply with regulatory requirements;
  • legal and compliance matters; and tax, trade and other regulatory matters.

We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. In evaluating those statements, you should specifically consider various factors, including risks and uncertainties discussed in the Confidential Offering Memorandum. Additional information regarding these and other factors can be found in Item 1A. Risk Factors in our 2017 Annual Report on Form 10-K.                                  

For further information, please contact:
   
L Brands:  
Investor Relations Media Relations
Amie Preston Tammy Roberts Myers
(614) 415-6704 (614) 415-7072
apreston@lb.com communications@lb.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 7

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 9

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 9

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 15

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 11

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
New Jersey Homeowners Face Mold Risks in Crawl Spaces

Updated Category News Views 7

Understanding the Invisible Threat of Crawl Space Mold Crawl space mold—it hides in the shadows beneath your home, biding its time until it wreaks havoc on indoor air quality. In the context of New Jersey's environmental quirks, this isn't a trivial concern. With humidity hanging around like an unwanted guest and sneaky water intrusions, those dark nooks under houses...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 10

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 14

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 7

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 16

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading

Top 5 Most Recently Viewed Articles

Teleflex Strengthens Market Position with BIOTRONIK Acquisition

Updated Category News Views 175

Teleflex Completes Strategic Acquisition to Enhance Portfolio Teleflex Incorporated (NYSE: TFX), a renowned name in medical technology, proudly announces the successful completion of its acquisition of BIOTRONIK's Vascular Intervention business. This acquisition significantly bolsters Teleflex's interventional access portfolio and extends its influence in the cath lab,...

Continue Reading
Mattamy Homes Celebrates Third Year as Top Workplace in Florida

Updated Category News Views 88

Mattamy Homes Continues to Shine as a Leading Employer Award-winning homebuilder, Mattamy Homes, has been recognized for its exceptional workplace culture, securing the title of one of South Florida's Best Places to Work for the third consecutive year. This significant recognition comes from the South Florida Business Journal, which highlights companies excelling in team...

Continue Reading
Arbor Day Foundation's Ambitious Tree Distribution in Asheville

Updated Category News Views 296

Community Efforts to Replant Trees This month marks an important milestone for Asheville residents as the Arbor Day Foundation embarks on an ambitious mission to distribute 1,200 trees. This initiative is part of a larger effort to distribute a remarkable total of 10 million trees, aimed at supporting recovery for those affected by the devastating Hurricanes Helene and...

Continue Reading
Chevron Leads the Way as Most Shorted Security in August

Updated Category News Views 120

Chevron Tops the List of Shorted Securities in August The latest Shortside Crowdedness Report from Hazeltree reveals that Chevron was the most shorted stock in the Americas for August. This indicates a significant trend among market players who are eager to exploit short selling opportunities. Hazeltree, renowned for its expertise in treasury operations and smart...

Continue Reading
Regal Rexnord's Upcoming Earnings and Innovations Overview

Updated Category News Views 259

Regal Rexnord Corporation Upcoming Earnings Conference Call Regal Rexnord Corporation (NYSE: RRX) is preparing to share its financial journey with stakeholders, announcing an important earnings conference call scheduled for Thursday, October 30, 2025. The company plans to release its financial results on the eve of the call, ensuring that investors and analysts alike are...

Continue Reading